Webinar

Maximize Biopharma Data Generation With Highly Multiplexed Mass Spectrometry Imaging

Now Available On Demand!

Highly multiplexed protein expression profiling can be achieved by employing MALDI HiPLEX-IHC tissue imaging probes and their associated workflows.
The combination of MALDI imaging with fluorescence microscopy and histopathological staining enables you to uncover complex networks of biological interactions in cancer, aging and other biological research.
Metabolic cascade information during disease progression can now be connected with protein localization within tissue.

Map proteins, examine metabolic activity and dig deeper into cellular biology by adding spatial localization to your current methodologies. In this webinar, we’ll showcase this novel workflow, highlighting the benefits it can bring to your research.

Attend this webinar to:
  • Understand the targeted protein imaging capabilities of mass spectrometry
  • See examples of MALDI imaging in the pharma/biotech industry
  • Learn about true multiomics techniques for tissue analysis

Speaker Information:

Joey Latham Round
Dr. Joey C. Latham
Senior Director Multiomics Analysis and ED&I Global Ambassador
PTC Therapeutics
 
Fang Xie Round Image 2
Dr. Fang Xie
Associate Director and Associate Fellow
GSK
 
Attend this webinar to:
  • Understand the targeted protein imaging capabilities of mass spectrometry
  • See examples of MALDI imaging in the pharma/biotech industry
  • Learn about true multiomics techniques for tissue analysis

Now Available On Demand!

To view the promises that we make to you regarding your personal information, please view Bruker`s privacy policy. For questions related to privacy, please send your inquiry to privacy@bruker.com

If you prefer not to receive promotional e-mails from Bruker in the future, you can unsubscribe at any time here.

Information you provide will be shared with the sponsors for this content. Technology Networks or its sponsors may contact you to offer you content or products based on your interest in this topic. You may opt-out at any time.